CNBC U.S. Television
Jon Najarian
More
-
Carl Icahn is using options as his primary weapon of choice in the titanic battle over Herbalife.
-
Shares of Ziopharm Oncology gapped higher this week, and traders are betting on even larger gains ahead.
More From U.S. Television
Contact U.S. Television
-
THIS WEEK ON CNBC
TUESDAY
- 8:00pCrowd Rules
- 9:00pCrowd Rules
- 10:00pAmerican Greed
- 11:00pMad Money
WEDNESDAY
- 8:00pCrowd Rules
- 9:00pAmerican Greed
- 10:00pAmerican Greed
- 11:00pMad Money
THURSDAY
- 7:00pNHL Playoffs
- 9:00pAmerican Greed
- 10:00pAmerican Greed
- 11:00pMad Money
FRIDAY
- 8:00pThe Celebrity Apprentice
- 9:00pCrowd Rules
- 11:00pMad Money